November 28, 2018 – HSCA Statement on Senate HELP Committee Hearing on Reducing Costs through Innovation
September 21, 2018 – Comments of the Healthcare Supply Chain Association (HSCA) to FDA on Facilitating Competition and Innovation in the Biological Products Marketplace
September 19, 2018 – HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
August 21, 2018 – HSCA Releases Second Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
June 15, 2018 – HSCA Applauds Senate Judiciary Committee for Advancing the CREATES Act
June 7, 2018 – HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
May 31, 2018 – Comments of the Healthcare Supply Chain Association (HSCA) on Supported Lifetimes and Legacy Medical Devices
May 25, 2018 – HSCA Comments on FDA Bulk Substance Guidance
May 4, 2018 – HSCA Comments on DEA Proposed Rule on Opioid Production Limits
April 17, 2018 – HSCA Announces Healthcare Cybersecurity Key Considerations
March 9, 2018 – HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids